Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VivaGel (SPL7013) for Prevention of Recurrent Bacterial Vaginosis
NCT01437722Phase 2Completed
- Sponsor
- Starpharma
- Start
- Aug 2011
- Primary completion
- Dec 2012
- Modality
- Peptides, Polymer-based Nanoparticles
01
Overview
A Phase 2 trial of astodrimer in bacterial vaginosis (BV), sponsored by Starpharma. Started Aug 2011; status: completed.
02
Drugs
astodrimer
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT01437722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437722.